Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries has said that the FDA has granted tentative approval for the company's abbreviated new drug application to market lansoprazole delayed-release capsules, 15mg and 30mg.
Subscribe to our email newsletter
Lansoprazole delayed-release capsules are generic version of Tap Pharmaceutical’s gastric-acid pump inhibitor, Prevacid (lansoprazole) delayed-release capsules. According to IMS sales data, the brand product had annual sales of approximately $3.4 billion in the US for the 12 months ended September 30, 2007.